Here, the presence of survivin in more aggressive and poorly differentiated variants of oral SCC confirms and extends earlier reports of survivin expression in skin cancers (Chiodino et al, 1999; Grossman et al, 1999b), and suggests its potential predictive/prognostic impact for disease progression. This evidence concerns the gene BIRC5 and skin cancer.